Literature DB >> 23639606

Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants.

Calvin Q Pan1, Huai-Bin Zou, Yu Chen, Xiaohui Zhang, Hua Zhang, Jie Li, Zhongping Duan.   

Abstract

BACKGROUND & AIMS: Despite appropriate passive and active immunization, perinatal transmission of hepatitis B virus (HBV) still occurs in 5%-10% of infants born to women with high levels of viremia who test positive for the hepatitis B e antigen (HBeAg). We evaluated the effects of cesarean section delivery on perinatal transmission of HBV from women who tested positive for the hepatitis B surface antigen (HBsAg).
METHODS: We analyzed data from 1409 infants born to HBsAg-positive mothers through vaginal delivery (VD) (n = 673), elective caesarean section (ECS) (n = 496), or urgent cesarean section (UCS) (n = 240) who completed appropriate immunization against HBV. The prevention was assumed to have failed for infants who were HBsAg positive when they were 7-12 months old; this information was used to assess transmission rates.
RESULTS: HBV infection was transmitted to a smaller percentage of infants born by ECS (1.4%) than by VD (3.4%, P < .032) or UCS (4.2%, P < .020). UCS had no effect on vertical transmission, compared with VD (4.2% vs 3.4%, P = .593). Infants born by ECS had a significantly lower rate of vertical transmission than those born by non-ECS (1.4% vs 3.6%, P = .017). Women with HBV DNA levels <1,000,000 copies/mL did not transmit the infection to their infants, regardless of method of delivery. There were no differences in maternal or infant morbidity and mortality among the groups.
CONCLUSIONS: There is a significantly lower rate of vertical transmission of HBV infection to infants delivered by ECS, compared with those delivered vaginally or by UCS. Elective cesarean sections for HBeAg-positive mothers with pre-delivery levels of HBV DNA ≥1,000,000 copies/mL could reduce vertical transmission.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALT; CHB; ECS; HBIg; HBV; HBeAg; HBsAg; Immunoprophylaxis; MTCT; Mother-to-Child Transmission; Neonate; Prevention; UCS; ULN; VD; alanine aminotransferase; chronic hepatitis B; elective cesarean section; hepatitis B e antigen; hepatitis B immunoglobulin; hepatitis B virus; hepatitis B surface antigen; mother-to-child transmission; upper limit of normal; urgent cesarean section; vaginal delivery

Mesh:

Substances:

Year:  2013        PMID: 23639606     DOI: 10.1016/j.cgh.2013.04.026

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  23 in total

Review 1.  Management of hepatitis B in special populations.

Authors:  Kali Zhou; Norah Terrault
Journal:  Best Pract Res Clin Gastroenterol       Date:  2017-06-08       Impact factor: 3.043

2.  A disappearing vertical infection: will hepatitis B be a forgotten disease in children?

Authors:  Byung-Ho Choe
Journal:  Korean J Intern Med       Date:  2014-04-29       Impact factor: 2.884

3.  Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.

Authors:  Gonzague Jourdain; Nicole Ngo-Giang-Huong; Linda Harrison; Luc Decker; Woottichai Khamduang; Camlin Tierney; Nicolas Salvadori; Tim R Cressey; Wasna Sirirungsi; Jullapong Achalapong; Prapap Yuthavisuthi; Prateep Kanjanavikai; Orada P Na Ayudhaya; Thitiporn Siriwachirachai; Sinart Prommas; Prapan Sabsanong; Aram Limtrakul; Supang Varadisai; Chaiwat Putiyanun; Pornnapa Suriyachai; Prateung Liampongsabuddhi; Suraphan Sangsawang; Wanmanee Matanasarawut; Sudanee Buranabanjasatean; Pichit Puernngooluerm; Chureeratana Bowonwatanuwong; Thanyawee Puthanakit; Virat Klinbuayaem; Satawat Thongsawat; Sombat Thanprasertsuk; George K Siberry; Diane H Watts; Nahida Chakhtoura; Trudy V Murphy; Noele P Nelson; Raymond T Chung; Stanislas Pol; Nantasak Chotivanich
Journal:  N Engl J Med       Date:  2018-03-08       Impact factor: 91.245

Review 4.  Hepatitis B and C in pregnancy: a review and recommendations for care.

Authors:  J C Dunkelberg; E M F Berkley; K W Thiel; K K Leslie
Journal:  J Perinatol       Date:  2014-09-18       Impact factor: 2.521

Review 5.  Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities.

Authors:  Jodie Dionne-Odom; Basile Njei; Alan T N Tita
Journal:  Clin Ther       Date:  2018-07-05       Impact factor: 3.393

6.  Ongoing Transmission of HCV: Should Cesarean Section be Justified? Data Mining Discovery.

Authors:  Abd Elrazek; Samy Saab; Mahmoud Foad; Elsayed A Elgohary; Mohammad M Sallam; Abdallah Nawara; Ali Ismael; Samar S Morsi; Altaher Salah; Mohamed Alboraie; Akshaya Srikanth Bhagavathula; Marwa Zayed; Hossam Elmasry; Tamer Z Salem
Journal:  J Transl Int Med       Date:  2017-03-31

Review 7.  Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission.

Authors:  Naichaya Chamroonkul; Teerha Piratvisuth
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

8.  Hepatitis B in Pregnancy.

Authors:  Tram T Tran
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

Review 9.  Current recommendations of managing HBV infection in preconception or pregnancy.

Authors:  James S Park; Calvin Pan
Journal:  Front Med       Date:  2014-05-29       Impact factor: 4.592

10.  ACG Clinical Guideline: Liver Disease and Pregnancy.

Authors:  Tram T Tran; Joseph Ahn; Nancy S Reau
Journal:  Am J Gastroenterol       Date:  2016-02-02       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.